Anne-Marie GRAFFIN

Filings by Anne-Marie GRAFFIN span 2 companies, the busiest being Valneva SE and Nanobiotix. We count 4 filings; the first trade dates from 3 October 2024 and the latest from 3 November 2025.

The open-market record is one-sided, with 4 purchases worth €90k and not one sale. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. In 2025 alone, the filings show 3 purchases and no sales.

In size, the median ticket on the buying side is €23k. 2 out of 4 purchases came within 30 days of a purchase by at least one other insider of the same company. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase.

Most recently, on 4 November 2025, the filings show an open-market purchase worth €15k in Valneva SE. Filings reach the AMF feed a median of 2 days after the trade. For comparison, MAR article 19 gives managers three business days to notify a trade. These figures are compiled from regulatory filings published by AMF. They describe what insiders did and are not a recommendation.